Corbus Pharmaceuticals

-$0.0305 (-10.80%) Today
+$0.0213 (+8.46%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBP and other ETFs, options, and stocks.

About CRBP

Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its products include candidate, Lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes.

CEO
Yuval Cohen
Employees
41
Headquarters
Norwood, Massachusetts
Founded
2009

CRBP Key Statistics

Market cap
31.80M
Price-Earnings ratio
—
Dividend yield
—
Average volume
675.81K
High today
$0.3079
Low today
$0.2503
Open price
$0.2957
Volume
965.11K
52 Week high
$1.97
52 Week low
$0.208

CRBP Earnings

-$0.43
-$0.29
-$0.14
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure